Vaccine Recommendations of the ACIP
Advisory Committee for Immunization Practices (ACIP)
MMR ACIP Vaccine Recommendations
(Measles, Mumps and Rubella)
as Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
- MMWR, June 14, 2013, Vol 62, #RR-04
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary: Recommendations of the ACIP
Print version [40 pages]
- See also:
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, June 9, 2006, Vol 55, #22
Notice to Readers: Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) for the Control and Elimination of Mumps
Print version [24 pages]
- MMWR, December 14, 2001, Vol 50, #49
Notice to Readers: Revised ACIP Recommendation for Avoiding Pregnancy After Receiving a Rubella-Containing Vaccine
Print version [28 pages]
- MMWR, May 22, 1998, Vol 47, #RR-8
MMR—Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps (.pdf version not available)
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.